BioNTech SE Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by BioNTech SE, a foreign private issuer, for the month of June 2025. The filing date is June 17, 2025. The document serves to disclose corporate governance updates rather than financial performance results.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or operational metrics.
Material Changes
The material change disclosed in this filing is the registration of an English translation of BioNTech SE's current Articles of Association with the commercial register (Handelsregister) of the local court (Amtsgericht) of Mainz, Germany. These articles became effective as of May 30, 2025.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the submission of corporate bylaws.
Key Facts for Investors to Verify
- The effective date of the new Articles of Association is May 30, 2025.
- The filing includes an English translation of the Articles of Association as Exhibit 99.1.
- The report was signed by Jens Holstein (Chief Financial Officer) and Dr. Sierk Poetting (Chief Operating Officer).
- No financial performance data is included in this specific filing.